Amplification of the Telomerase RNA Component Gene in the Process of Human Esophageal Carcinogenesis

Amplification of the Telomerase RNA Component Gene in the Process of Human Esophageal Carcinogenesis

QIANG CHEN,¹ XINSHUAI WANG,¹ YI RU,¹ SHUCHANG CHEN,¹ SHEGAN GAO,¹ LUQI XING,¹ JIANQIANG MI,¹ YUFENG WANG,¹ ZHONGYUE XIAO¹ and XIAOSHAN FENG¹

¹Department of Oncology, Cancer Institute, First Affiliated Hospital of Henan University of Science and Technology, Luoyang, P.R. China

Amplification of the human telomerase RNA component (hTERC) gene occurs early in cervical cancer development. Telomerase, the product of the hTERC gene, plays an important role in tumor cell apoptosis and genomic stability. Given the numerous similarities between esophageal and cervical cancers, we hypothesized that hTERC gene amplification may also be related with esophageal cancer development. We therefore examined 189 tissue sections from 63 cases of esophageal cancer and preneoplastic lesions. hTERC gene amplification in the lesions was detected by interphase fluorescence in situ hybridization. Of the 189 tissue sections, 149 were successfully evaluated (40 samples were excluded because of inappropriately preparation) and were classified as normal (n = 45), atypical hyperplasia I (n = 27), atypical hyperplasia II/III (n = 22), and squamous cell carcinomas (SCCs; the most common type of esophageal cancer) (n = 55). hTERC gene expression was not detected in normal esophageal tissue, whereas its expression was detected in atypical hyperplasias I (25.9%), atypical hyperplasia II/III (54.5%), and SCCs (90.9%) (p < 0.05). The average copy numbers of hTERC in atypical hyperplasias I and II/III, as well as SCCs were 2.19, 2.35, and 2.64, respectively. In particular, the numbers of abnormal nuclei in atypical hyperplasias II/III were significantly higher than those of in atypical hyperplasia I (p < 0.05). The hTERC gene amplification was not related with patient gender, histological stage, lymph nodes metastasis, and SCC differentiation grade (p > 0.05). All these findings suggest that hTERC gene amplification is associated with SCC development.

keywords —— esophageal cancer; fluorescence in situ hybridisation; gene amplification; human telomerase RNA component; telomerase

===============================

Tohoku J. Exp. Med., 2011, 224, 99-104

Correspondence: Xiaoshan Feng, M.D., Ph.D., Department of Oncology, Cancer Institute, First Affiliated Hospital, Henan University of Science and Technology, Luoyang, 471003, P.R. China.

e-mail:Samfeng137@126.com